Date Name Title Filing Type Shares Traded Price Range Total Held
Oct 17, 2013 Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 20,000 -- --
Sep 10, 2013 SVP - Global Franchise Leader Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 905 $11.26 14,290
Sep 09, 2013 Director, President and CEO Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 2,261 $11.10 74,290
Sep 04, 2013 VP - Global Franchise Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 795 $10.96 25,520
Sep 04, 2013 SVP, GM - Oncology Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 835 $10.96 27,245
Aug 08, 2013 Director Form 4 Other acquisition or disposition -- -- 4,000
Aug 08, 2013 Director Form 4 Other acquisition or disposition -- -- 38,000
Aug 08, 2013 Director Form 4 Other acquisition or disposition -- -- 13,000
Aug 08, 2013 Director, Ten Percent Owner Form 4 Other acquisition or disposition -- -- 5,848,255
Aug 08, 2013 Director, Ten Percent Owner Form 4 Other acquisition or disposition -- -- 1,542,132
 For recent transactions, including derivative transactions, see our Section 16 SEC filings page.